We are live on ! Find out more
PAVMW

PAVmed Inc. Warrant

Delisted

PAVMW was delisted on the 28th of January, 2022.

3 hedge funds and large institutions have $13K invested in PAVmed Inc. Warrant in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

25% less funds holding

Funds holding: 43 (-1)

46% less capital invested

Capital invested by funds: $24K → $13K (-$11K)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
WAM
1
Wolverine Asset Management
Illinois
$10K -$14.5K -15,001 -66%
UBS Group
2
UBS Group
Switzerland
$2K +$611 +631 +94%
AF
3
Allworth Financial
California
$1K +$387 +400 New
VF
4
Virtu Financial
New York
-$9K -20,911 Closed
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
-$6K -14,078 Closed

PAVMW Hedge Fund Activity: Q1 2021 in Review

3 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Warrant (PAVMW) for Q1 2021, worth a combined $13K — down 46% from $24K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of PAVMW and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $611. The largest seller was Wolverine Asset Management, cutting an estimated $14.5K.

  • 3 institutional investors held PAVmed Inc. Warrant (PAVMW) as of Q1 2021, down from 4 in Q4 2020.
  • Funds reported $13K of PAVmed Inc. Warrant stock for Q1 2021, down 46% quarter-over-quarter.
  • 1 fund opened new PAVmed Inc. Warrant positions in Q1 2021 and 2 closed out, a net change of -1 holder.
  • The largest PAVmed Inc. Warrant buyer in Q1 2021 was UBS Group, an estimated $611 added.
  • The largest PAVmed Inc. Warrant seller in Q1 2021 was Wolverine Asset Management, an estimated $14.5K sold.

Based on aggregated 13F filings for Q1 2021.